Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in 4 major cities in the United States. [PDF]
Lazarus JV +16 more
europepmc +1 more source
The Reversibility of Urate Tophi With Treat-to-Target in Gout: All Gone. Forever? [PDF]
Singh JA.
europepmc +1 more source
Statistical modelling of an outcome variable with integrated multi-omics. [PDF]
Li H +3 more
europepmc +1 more source
Norseman and Native in the Kingdom of the Isles: A Reassessment of the Manx Evidence
Basil R. S. Megaw
doaj
Letter: Safety and Tolerability of Injectable Extended-Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol-Associated Liver Disease-Authors' Reply. [PDF]
Díaz LA, Loomba R.
europepmc +1 more source
A Pilot Investigation on the Relationship Between Infant Vocal Characteristics at 12 Months and Speech Motor Impairment at 4-5 Years. [PDF]
Long HL, Jensen S, Hustad KC.
europepmc +1 more source
Efficient candidate drug target discovery through proteogenomics in a Scottish cohort. [PDF]
Kuliesius J +4 more
europepmc +1 more source
Association between pattern of hepatic iron deposition and severity of MASH among patients enrolled in the NASH Clinical Research Network. [PDF]
Sohal A +11 more
europepmc +1 more source
Geneticization in the genomic era: a scoping review of ethical, clinical, and sociocultural transformations. [PDF]
Shaheen S, Ghaly M.
europepmc +1 more source

